NaF and FDG PET/CT in Detection of Occult Metastatic Disease in Recurrence of Prostate Cancer
H Jadvar, B Desai, L Ji, P.S. Conti, T.B. Dorff, S.G. Groshen, M.E. Gross, J.K. Pinski and D.I. Quinn | 2012-07-01
18F NaF and 18F FDG PET/CT were evaluated for their ability to detect occult metastatic disease in cases of prostate cancer relapse. Study shows that 18F NaF is useful in detecting occult osseous metastases, whereas the 18F FDG yield is more limited.